These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 9035229

  • 1. Mortality studies and the effectiveness of drugs in long-term treatment.
    Ahrens B.
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):57-61. PubMed ID: 9035229
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
    Dardennes R, Lafuma A, Watkins S.
    Encephale; 1999 Jan; 25(5):391-400. PubMed ID: 10598301
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C, Gruschka P, Berghöfer A, Bauer M, Müller-Oerlinghausen B, Bschor T, Smolka MN.
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP).
    Linden M, Baier D, Beitinger H, Kohnen R, Osterheider M, Philipp M, Reimitz DE, Schaaf B, Weber HJ.
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):65-70. PubMed ID: 9035231
    [Abstract] [Full Text] [Related]

  • 11. Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients.
    Nilsson A.
    Pharmacopsychiatry; 1995 Jan; 28(1):8-13. PubMed ID: 7746844
    [Abstract] [Full Text] [Related]

  • 12. [Predictors of prophylactic response to lithium].
    Rohayem J, Baylé JF, Richa S.
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [Abstract] [Full Text] [Related]

  • 13. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
    Juckel G, Mavrogiorgou P, Bredemeier S, Gallinat J, Frodl T, Schulz C, Möller HJ, Hegerl U.
    Pharmacopsychiatry; 2004 Mar; 37(2):46-51. PubMed ID: 15048610
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H, Kennedy WK, Dorfman JH, Fincham JE, Reeves J, Martin BC.
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [Abstract] [Full Text] [Related]

  • 18. Saliva for monitoring of patients with primary affective disorders.
    Ben-Aryeh H, Laor R, Szargel R, Gutman D, Naon H, Pascal M, Hefetz A.
    Isr J Med Sci; 1984 Mar; 20(3):197-201. PubMed ID: 6427134
    [Abstract] [Full Text] [Related]

  • 19. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A, Gonnier V, Aussilloux C.
    Encephale; 2002 Mar; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [Abstract] [Full Text] [Related]

  • 20. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N, Greil W.
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.